ArticleDrug safety2026
Strengthening Signal Detection by Proactive Adverse Event Case Identification in Electronic Health Records Using a Text-Mining Tool.
Article in Drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe spontaneous reporting system is the cornerstone of pharmacovigilance but is limited by substantial underreporting, which may delay safety signal detection.
objectiveThe aim of this study was to evaluate the electronic health record-adverse event search method for identifying and reporting additional potential adverse drug reactions in electronic health records to strengthen routine signal detection.
methodsBetween August 2022 and August 2025, targeted searches for adverse drug reactions were conducted in approximately 2,750,000 electronic health records from two Dutch hospitals using a data collection text-mining tool. Search criteria were derived from information in spontaneous reports of specific drug-adverse event associations. Structured (e.g. laboratory results, medication prescriptions) and unstructured (e.g. clinical notes, hospital discharge letters) data were used to identify potential adverse drug reactions. Identified cases were manually verified and, when relevant, reported to the Netherlands Pharmacovigilance Centre Lareb and analysed alongside spontaneous reports for signal detection.
resultsA total of 147 electronic health record-derived cases were reported for 41 drug-adverse event associations. These contributed to 34 signal detection analyses, supporting the assessment of seven safety signals. In 75% of the cases, a suspected causal relationship was documented by healthcare professionals in clinical notes. Electronic health record-derived cases accounted for up to 73% of the reports included in the seven detected signals.
conclusionsThis study demonstrates that electronic health records can be used as an additional source of individual case safety reports in routine pharmacovigilance practice, supporting the further assessment of selected potential safety signals. Despite limitations related to efficiency, this proactive approach has potential to address underreporting and complement the spontaneous reporting system, strengthening signal detection.
Identifiers
42900349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.